Speakers

Sudhir Agrawal

President and Founder

Arnay Sciences

Daniel Blessing

CTO

HAYA Therapeutics

Jacob Borrajo

CEO

Amber Bio

Bhawanjit Brar

CEO

Jaan Biotherapeutics

Ivan Burkov

Partner

INKEF Capital

Hagen Cramer, PhD

Chief Technology Officer

QurAlis

Dee Datta

Co-founder & CEO

Switch Therapeutics

Mr Mark Dickman

Professor

University of Sheffield

Miroslav Gaparek

CEO

Sensible Biotechnologies

Malgorzata Gonciarz

Global Head xRNA Therapeutics

Novartis

Tamar Grossman

CEO

La Jolla Labs

Nicola Guzzi

Associate Principal Scientist

AstraZeneca

Bo Rode Hansen, Ph.D.

Global Head RTR & GM RICC, RTR (RNA Rx Research)

Roche Innovation Center Copenhagen, Denmark

Lorna Harries

CSO

Senisca

Mr Michael Hodges

CEO

1Strand

Arun Kumar

RNA Innovations Programs Leader

CEPI

Nick Lench

Executive Director

Nucleic Acid Therapy Accelerator

Marie-Hélène Leopold

CCO

AGS Therapeutics

Beatriz Llamusi, PhD

Chief Executive Officer & Co Founder

Arthex Biotech S.L.

Cesar Lopex

Group Leader

University Of Oxford

Dr. Sonja Merkas, PhD

Founder, Creator and Doer

Livinovea

Sanjay Mistry

Head of Alternative Credit

Pension Protection Fund

Paul Nioi, PhD

SVP

Alnylam Pharmaceuticals, Inc.

Christopher O'Donnell

Global Head of Cardiovascular & Metaboli

Novartis

Steve Pascolo

Researcher (Former Founder, CureVac)

University Hospital of Zurich

Ms Paola Pozzi

Partner, Sofinnova Telethon Fund

Sofinnova Partners

Bogdan Rivoal

Group Leader

University Of Zürich

Felix Schumacher

Program Leader Targeted Therapeutics

Roche

Poul Sørensen

CEO

Inverna therapeutics

John Taylor

Global Head of Business Development

Ribocure

Manuel Vega

CEO

AGS Therapeutics

Philippe Vollmer Barbosa

Project Manager

Fraunhofer

Nathaniel Wang, PhD

CEO

Replacate Biosciecne

Mr Peter Weinstein

Chief Executive Officer

EmerVax

Erik Digman Wiklund

CEO

Circio AB

Marie Wikstrom-Lindholm

SVP and Head of Molecular Design

Silence Therapeutics

Renee Williams

Founder and Managing Partner

Williams Biotech Consulting, LLC

Michael Wolfinger

Principal Investigator

University of Vienna

Emily Young

Director of Scientific Applications

4Basebio